Rob Holgate, Ph.D.

VP, Research and Innovation
Abzena, United Kingdom

Poster(s):

• (W1230-02-07) EpiScreen®2.0 Time Course Assay: A Sensitive and Data Rich Tool for Pre-Clinical Immunogenicity Testing of Biologics
  Wednesday, October 23, 2024

  12:30 PM – 1:30 PM MT

• (M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
  Monday, October 21, 2024

  3:30 PM – 4:30 PM MT